Read oxford vaccine latest news on The Economic Times. oxford vaccine updates, oxford vaccine developments, videos and more.

Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.

Dr. Anthony Fauci launched a COVID-19 vaccine study on pregnant women after he privately theorized that the injection could potentially cause miscarriages.

Moderna announced an update on their ongoing clinical study. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investme ...

Vaccines that protect against severe illness, death and lingering long Covid symptoms from a coronavirus infection were linked to small increases in neurological, blood, and heart-related conditions ...

Although there are many possibilities for what researchers can use mRNA to treat, some important limitations remain ...

The vaccine, called mFlusiva, was approved for older adults. In trials, it was found to be about 27% more effective than a ...

European Commission grants marketing authorization for Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine for the 2026-2027 season in the EU. Approval covers use in individuals aged 6 months and older ...

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (“LNP”) technology against Pfizer and ...

The cases add to a web of high-stakes patent lawsuits filed by biotech companies against Pfizer and Moderna over the mRNA technology used in their COVID vaccines. Spokespeople for Pfizer and Moderna ...

As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new front to challenge the companies’ blockbuster COVID-19 vaccines. In ...